Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kayyem Jon Faiz
Relationship:  
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   375,074    

Indirect Shares

   10,693,978      
Direct Value   $4,750,833    

Indirect Value

   $17,161,998      
Total Shares   11,069,052      
Total Value   $21,912,830      


Genmark Diagnostics, Inc. $4,750,833 Biodesix Inc $0 Genmark Diagnostics, Inc. $4,750,833 Biodesix Inc $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aeolus Pharmaceuticals Inc AOLS 10% Owner 0 2006-06-05 9,800,000    Premium*  
            Genmark Diagnostics, Inc. GNMK SVP, Research & Develo... 2018-02-02 197,622 2018-02-02 713,893    Premium*  
            Inhibrx, Inc. INBX Director 2022-08-02 0 2024-05-30 0    Premium*  
            Biodesix Inc BDSX 2023-08-03 177,452 2023-08-03 180,085    Premium*  
* Premium Members only  

Records found :    91         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2014-12-15 4 AS $12.51 $4,066 D/D (325) 108,448 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2017-11-20 4 S $4.74 $6,015 D/D (1,269) 197,905 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2016-03-01 4 S $4.93 $6,828 D/D (1,385) 153,796 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2015-06-03 4 AS $9.53 $8,930 D/D (937) 107,165 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2015-12-02 4 S $7.60 $9,036 D/D (1,189) 104,179 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2016-02-03 4 S $4.99 $9,561 D/D (1,916) 101,894 0 -
BDSX Biodesix Inc   •       •      –    2023-08-03 4 A $1.62 $9,999 I/I 6,172 180,085 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2015-09-02 4 AS $9.62 $10,053 D/D (1,045) 105,750 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2017-08-21 4 S $9.45 $12,068 D/D (1,277) 199,442 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2014-06-03 4 AS $10.67 $13,103 D/D (1,228) 110,236 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2013-08-20 4 S $10.15 $13,297 D/D (1,310) 108,351 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2014-03-11 4 AS $12.17 $14,843 D/D (1,220) 111,464 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2014-09-05 4 AS $10.04 $15,120 D/D (1,506) 109,261 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2014-12-04 4 AS $12.06 $15,919 D/D (1,320) 108,773 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2017-05-19 4 S $12.89 $16,306 D/D (1,265) 200,989 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2013-09-03 4 S $11.60 $17,922 D/D (1,545) 106,806 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2013-12-04 4 AS $11.14 $19,662 D/D (1,765) 106,155 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2015-03-11 4 AS $11.71 $32,203 D/D (2,750) 108,102 0 -
GNMK Genmark Diagnostics, Inc. Chief Scientific Officer   •       –      –    2013-03-14 4 S $11.88 $51,702 D/D (4,352) 109,661 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2017-02-21 4 S $10.08 $52,920 D/D (5,250) 154,079 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2013-07-01 4 AS $10.40 $62,400 I/I (6,000) 112,934 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2014-10-31 4 AS $11.01 $66,060 I/I (6,000) 82,934 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2014-05-28 4 AS $11.06 $66,378 I/I (6,000) 94,934 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2015-03-09 4 AS $12.06 $67,235 D/D (5,575) 111,185 0 -
GNMK Genmark Diagnostics, Inc. SVP, Research & Development   •       –      –    2017-01-19 4 S $12.47 $71,303 D/D (5,718) 159,460 0 -
  91  Records found
  1   2   3  4      
  Page 3 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us